Marksans-Pharma Stock/Share Prices, Buy and Sell Marksans-Pharma BSE Stocks

Market Snapshot

BSE Sensex: 50193.33 1.24%
BSE 500: 20446.42 1.32%
BSE 200: 6535.46 1.31%
BSE 100: 15358.8 1.29%
BSE Mid-Cap: 21232.21 1.87%
BSE Small-Cap: 22847.9 1.28%
BANKEX: 38528.89 1.24%
BSE IT Sector: 26571.84 0.87%
Nifty 50: 15108.1 1.24%
Nifty 500: 12839.1 1.32%
Nifty 200: 7969.4 1.33%
Nifty 100: 15325 1.26%
Nifty Midcap 100: 25266.65 1.83%
Nifty Small 100: 8999.85 1.59%
Nifty IT: 25958.25 0.99%
Nifty PSU Bank: 2248.7 -1.27%

News:

Tata Motors Q4 net loss narrow...
Torrent Pharma Q4 PAT rises 3%...
Jyothy Labs rises after Q4 PAT...
3M India gains as Bangalore pl...
Abbott India Q4 PAT jumps 37% ...

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

18 May 2021 | 03:59 PM

75.50

3.50 (4.86%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

280.35%

Return (1Y)

Beaten S&P BSE Healthcare by 218.35%
More Volatile

3.61%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 2.35%
Consistent Performer

7/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

News & Announcements

Marksans Pharma consolidated net profit rises 99.39% in the December 2020 quarter
99 days ago

Marksans Pharma consolidated net profit rises 99.39% in the December 2020 quarter

08 - Feb - 2021 12:00 AM | 99 days ago

Net profit of Marksans Pharma rose 99.39% to Rs 58.94 crore in the quarter ended December 2020 as against Rs 29.56 crore during the previous quarter ended December 2019. Sales rose 24.58% to Rs 358.36 crore in the quarter ended December 2020 as against Rs 287.65 crore during the previous quarter ended December 2019.
Particulars Quarter Ended
Dec. 2020 Dec. 2019 % Var.
Sales 358.36 287.65 25
OPM % 25.41 16.44 -
PBDT 86.22 45.66 89
PBT 77.64 38.34 103
NP 58.94 29.56 99
Powered by Capital Market - Live News
Marksans Pharma to conduct board meeting
110 days ago

Marksans Pharma to conduct board meeting

28 - Jan - 2021 12:00 AM | 110 days ago

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 8 February 2021.
Powered by Capital Market - Live News
Marksans Pharma consolidated net profit rises 95.34% in the September 2020 quarter
193 days ago

Marksans Pharma consolidated net profit rises 95.34% in the September 2020 quarter

06 - Nov - 2020 12:00 AM | 193 days ago

Net profit of Marksans Pharma rose 95.34% to Rs 50.73 crore in the quarter ended September 2020 as against Rs 25.97 crore during the previous quarter ended September 2019. Sales rose 39.03% to Rs 356.47 crore in the quarter ended September 2020 as against Rs 256.40 crore during the previous quarter ended September 2019.
Particulars Quarter Ended
Sep. 2020 Sep. 2019 % Var.
Sales 356.47 256.40 39
OPM % 23.33 13.09 -
PBDT 84.89 38.64 120
PBT 65.90 33.66 96
NP 50.73 25.97 95
Powered by Capital Market - Live News
Marksans Pharma to table results
202 days ago

Marksans Pharma to table results

28 - Oct - 2020 12:00 AM | 202 days ago

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 6 November 2020.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Marksans Pharma Ltd has decreased by -33.89% since past 3 Months
MF shareholding in Marksans Pharma Ltd has increased by 660.66% since past 3 Months
FII shareholding in Marksans Pharma Ltd has increased by 31.15% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2020	Dec. 2019	% Var.
Sales	358.36	287.65	25
OPM %	25.41	16.44	-
PBDT	86.22	45.66	89
PBT	77.64	38.34	103
NP	58.94	29.56	99

Particulars	Quarter Ended
	Sep. 2020	Sep. 2019	% Var.
Sales	356.47	256.40	39
OPM %	23.33	13.09	-
PBDT	84.89	38.64	120
PBT	65.90	33.66	96
NP	50.73	25.97	95

General Notifications

My Notifications

Research Notifications

Marksans Pharma Ltd NSE / BSE Pharmaceuticals, Small Cap

75.50 3.50 (4.86%)

News & Announcements

Price vs Volume

Stock Trivia

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Small Cap

75.50

3.50 (4.86%)